Acurx Pharmaceuticals, LLC is a biopharmaceutical company that develops antibiotics for the treatment of clostridium difficile infection (CDI) disease.
Founded in February 2018, Biothus is a pharmaceutical company, focused on antibody-based drugs to deal with cancer, immunotherapy and metabolic diseases.
The Life Sciences team at CFD Research Corporation creates new concepts, designs, and prototypes for military medicine and biomedical applications.
DeNovaMed is developing novel antibiotics to treat bacterial infections.
EnBiotix a is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins.
Encapsulation of Bacterial Pathogens
MicrobeDx uses rapid molecular testing for bacterium identification in 30-45 minutes and Antibiotic Susceptibility Testing in 3 hours or less.
Motif Bio (AIM/NASDAQ: MTFB) is a clinical-stage biopharmaceutical company focused on developing novel antibiotics to ...
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for human diseases. Its Reverse Translational Medicine™ platform generates recombinant human monoclonal ...
Peptilogics is an early-stage biotechnology company utilizing an innovative platform technology which enables us to rapidly and effectively develop novel peptide therapeutics, with a focus on ...
Antibiotic Small Molecules
Wintermute Biomedical is a US biopharmaceutical startup whose sole focus is to develop next-generation antibiotics in order to address the impending threat of antimicrobial resistance (AMR). ...